162 related articles for article (PubMed ID: 23129337)
1. Imaging as tool to investigate psychoses and antipsychotics.
Booij J; van Amelsvoort T
Handb Exp Pharmacol; 2012; (212):299-337. PubMed ID: 23129337
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
3. The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication.
da Silva Alves F; Figee M; van Amelsvoort T; Veltman D; de Haan L
Psychopharmacol Bull; 2008; 41(1):121-32. PubMed ID: 18362875
[TBL] [Abstract][Full Text] [Related]
4. [Receptor occupancy and antipsychotic drug action measured by PET and SPECT].
Okubo Y; Suhara T
Seishin Shinkeigaku Zasshi; 2001; 103(4):329-40. PubMed ID: 11392846
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.
Howes OD; Egerton A; Allan V; McGuire P; Stokes P; Kapur S
Curr Pharm Des; 2009; 15(22):2550-9. PubMed ID: 19689327
[TBL] [Abstract][Full Text] [Related]
6. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis.
Jann MW
Pharmacotherapy; 2004 Dec; 24(12):1759-83. PubMed ID: 15585443
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic drug action: targets for drug discovery with neurochemical imaging.
Stone JM; Pilowsky LS
Expert Rev Neurother; 2006 Jan; 6(1):57-64. PubMed ID: 16466312
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder.
Cumming P; Abi-Dargham A; Gründer G
Behav Brain Res; 2021 Feb; 398():113004. PubMed ID: 33197459
[TBL] [Abstract][Full Text] [Related]
9. Imaging studies - differential action of typical and atypical antipsychotics in a network perspective.
Vernaleken I; Cumming P; Gründer G
Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S60-9. PubMed ID: 18756422
[TBL] [Abstract][Full Text] [Related]
10. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia.
Vita A; De Peri L
Int Rev Psychiatry; 2007 Aug; 19(4):429-36. PubMed ID: 17671875
[TBL] [Abstract][Full Text] [Related]
11. Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.
Kasper S; Tauscher J; Küfferle B; Barnas C; Pezawas L; Quiner S
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():83-9. PubMed ID: 10654113
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology of schizophrenia and its impact on pharmacotherapy].
Widschwendter CG; Fleischhacker WW
Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S32-7. PubMed ID: 16270242
[TBL] [Abstract][Full Text] [Related]
13. [Dopaminergic receptor activity and the evolution of schizophrenia].
Fodoreanu L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
[No Abstract] [Full Text] [Related]
14. [The mechanisms of action of antipsychotic drugs: is atypicality superior in schizophrenia treatment?].
Anil Yağcioğlu AE
Turk Psikiyatri Derg; 2007; 18(4):364-74. PubMed ID: 18066727
[TBL] [Abstract][Full Text] [Related]
15. [Distribution and function of dopamine D1, D2 receptor].
Suhara T; Miyoshi M
Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
[TBL] [Abstract][Full Text] [Related]
16. [A biochemical theory of schizophrenia].
Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
[TBL] [Abstract][Full Text] [Related]
17. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
18. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
Maćkowiak M; Czyrak A; Wedzony K
Psychiatr Pol; 2000; 34(4):607-21. PubMed ID: 11059260
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.
Laruelle M; Frankle WG; Narendran R; Kegeles LS; Abi-Dargham A
Clin Ther; 2005; 27 Suppl A():S16-24. PubMed ID: 16198197
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.
Erritzoe D; Talbot P; Frankle WG; Abi-Dargham A
Neuroimaging Clin N Am; 2003 Nov; 13(4):817-32. PubMed ID: 15024964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
